Arun Janapala

Enhancing Medical Review of ICSRs with Affinity Analysis
||
During the medical review of Investigational New Drug (IND) SUSARs, FDA mandates sponsors to diligently identify analogous suspected adverse events previously documented and systematically evaluate the current safety report within the context of these previously submitted cases. This analytical process...
continue reading
Business Process Transformation in Pharmacovigilance
||
Designing a case workflow, defining user profiles, configuring the product and study library, and establishing submission rules are critical components when envisioning a new future state for business processes. Having had several discussions with different clients, it has become clear...
continue reading
Social media & sharing icons powered by UltimatelySocial